Is Parkinson's an Autoimmune Disease?
-
T-Cells
-
According to "International Journal of Neuroscience," both disruption of the function of T-cells, which are critical to the immune response, and the presence of autoimmune antibodies are seen in some Parkinson's patients.
Vasoactive Neuropeptides
-
Particular vasoactive neuropeptides (neurotransmitters that regulate blood vessel dilation and dopamine distribution) can be affected by autoimmunity, and compromised receptors for these cells have been shown in Parkinson's.
Inflammation
-
The American Academy of Neurology published a population-based clinical study showing that autoimmune diseases increase the activity of inflammatory regulators, which can cause decay of dopaminergic neurons--the root cause of Parkinson's.
Pathway of Inflammatory Mediators
-
The pituitary adenylate cyclase-activating peptide (PACAP), which prevents neurotoxicity, and vasoactive neuropeptides (VP) do not properly regulate inflammatory mediators in Parkinson's patients.
Prevention
-
Research on the role of autoimmunity role in Parkinson's, if verified, may lead to pharmacological targets to prevent the disease in the future.
-